SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
63382 357 15 IMMU
Emcee:  idahoranch1 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
62161Anavex appoints David Goldenberger as their Senior VP of Regulatory Affairs. Soweatherproof-11/9/2023
62160Gilead got hammered today, although it came back a bit from earlier lows this mojargonweary411/8/2023
62159OT: I use this story as my introduction to my Statistics 101 class. Did have onejhcimmu-11/8/2023
62158OT: About smell.... OK, this is sparked by Dr. Gs novel and is actually unrelaterickerickson211/8/2023
62157I'll be waiting for James Patterson to have Dr.G co author a novel with himEMU2-11/7/2023
62156Honestly….you can’t make this stuff up.jargonweary111/7/2023
62155Dr. G. davidmgoldenberg.comsysiphus711/7/2023
62154SAVA Completes Enrollment: cassavasciences.comDavidoff511/6/2023
62153MCRB got back to cash level today. I trimmed some recently (15%), but it feels Stanley Lake 92211/3/2023
62152MCRB is on sale. Trading under cash value at today's open ($133M market cap ghettogoulash-11/3/2023
62151Alzheon is enrolling just 325 patients in its Phase 3 trial, so they are obviousghettogoulash-11/2/2023
62150CLLS showing signs of life. Unfortunately I bought at about 3x current price. fsysiphus-11/2/2023
62149AD treatment showing promise could be a competitor to simufilam alzheon.com Hescorman1111/2/2023
62148Just to add a little more color to Doc's post: In the conference call Mondaybodish211/1/2023
62147I'm holding my SRPT. I have 10% of my portfolio here (a bit less now, more stockdoc77511/1/2023
62146SRPT: The timing of this one could have been better: Sarepta Therapeutics Annoerickerickson-11/1/2023
62145My SRPT position was never large. By the time I got into SRPT my basis was $77 aOlecranon210/31/2023
62144Well. If someone HAD told you that is very hard to make money in biotech you migjargonweary210/31/2023
62143The P3 results were disappointing. Not sure what happens with their AA but I thstockdoc77110/31/2023
62142SRPT getting hammered pre-market: Pre-market is pretty brutal, down $47. As alwerickerickson-10/31/2023
62141SRPT topline data released. Stock halted until conference call ends. SRPT is KeeptheFaith-10/30/2023
62140I'm out of free articles on SA. I'll try a work around.Stanley Lake 92-10/30/2023
62139seekingalpha.comsysiphus110/30/2023
62138Paywall: x.com Based on post replies, Adam remains unloved by many.Stanley Lake 92-10/30/2023
62137Heard that Adam Feurstein was coming out with a negative reply, today, to SAVA lgalt-10/30/2023
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News